Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
CSP.L Share News (CSP)
CSP Share
Price
CSP Share
News
CSP Share
Chat
CSP Share
Trades
CSP
Live RNS
CSP Share
Charts
CSP Broker
Ratings
CSP Directors
Deals
CSP Financial
Diary
CSP
Fundamentals
CSP Short
Positions
CSP
Media
CSP Company
Research
CSP Company
Timeline
- There is currently no data for CSP
Wednesday broker round-up
Barclays: Berenberg reiterates buy with a target price of 220p.
Aston Martin: Citigroup reiterates buy with a target price of 2,800p.
Segro: JP Morgan reiterates neutral with a target price of 1,195p.
Sainsbury: Barclays reiterates overweight with a target price of 305p.
GlaxoSmithKline: Liberum reiterates buy with a target price of 1,700p.
On The Beach: Liberum reiterates hold with a target price of 380p.
888 Holdings: Peel Hunt reiterates buy with a target price of 500p.
Countryside Properties: Peel Hunt reiterates buy with a target price of 560p.
Redrow: Numis reiterates buy with a target price of 715p.
Accesso: Numis upgrades to buy with a target price of 800p.
International Airlines Group: Credit Suisse reiterates outperform with a target price of 256p.
Centrica: Credit Suisse reiterates outperform with a target price of 70p.
Latest CSP News
- Countryside Properties revenues rise but profits hit by writedown
13 May 2021 - BROKER RATINGS: Vodafone on Goldman Sachs' Conviction Buy List
11 May 2021 - UK earnings, trading statements calendar - next 7 days
6 May 2021 - EXECUTIVE CHANGES: New chairs for Naked Wines, Countryside Properties
13 Apr 2021 - UPDATE: Countryside responds to UK CMA about "unfair" contract terms
19 Mar 2021 - TOP NEWS: UK CMA tells housebuilders to remove "unfair" contract terms
19 Mar 2021 - LONDON BRIEFING: Europe starts to resume use of AstraZeneca vaccine
19 Mar 2021 - Taylor Wimpey and Countryside ordered to scrap unfair leases
19 Mar 2021
Related News
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug
GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...
GSK hails 'milestone' drug trial results in China
(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...
CSP.L News
Countryside Properties revenues rise but profits hit by writedown
(Sharecast News) - Countryside Properties backed its full-year expectations on Thursday as it reported a jump in revenue amid strength in the private ...
BROKER RATINGS: Vodafone on Goldman Sachs' Conviction Buy List
BROKER RATINGS: Vodafone on Goldman Sachs' Conviction Buy List
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
EXECUTIVE CHANGES: New chairs for Naked Wines, Countryside Properties
EXECUTIVE CHANGES: New chairs for Naked Wines, Countryside Properties
UPDATE: Countryside responds to UK CMA about "unfair" contract terms
UPDATE: Countryside responds to UK CMA about "unfair" contract terms
TOP NEWS: UK CMA tells housebuilders to remove "unfair" contract terms
TOP NEWS: UK CMA tells housebuilders to remove "unfair" contract terms
LONDON BRIEFING: Europe starts to resume use of AstraZeneca vaccine
LONDON BRIEFING: Europe starts to resume use of AstraZeneca vaccine
Taylor Wimpey and Countryside ordered to scrap unfair leases
(Sharecast News) - The UK's competition watchdog has ordered Taylor Wimpey and Countryside to tear up onerous ground rent terms that have left many le...
Follow the stocks
